Valneva SE ADR (VALN)

NASDAQ
37.44
-0.54(-1.42%)
  • Volume:
    21,802
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    36.69 - 37.85

VALN Overview

Prev. Close
37.67
Day's Range
36.69-37.85
Revenue
-
Open
36.69
52 wk Range
24.16-67.84
EPS
-
Volume
21,802
Market Cap
2.44B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
106,224
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
49,940,000
Next Earnings Date
24 Mar 2022
What is your sentiment on Valneva SE ADR?
or
Market is currently closed. Voting is open during market hours.

Valneva SE ADR Company Profile

Employees
700

Valneva SE, a specialty vaccine company, focused on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; and DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera and/or heat-labile toxin producing Enterotoxigenic Escherichia coli bacterium. The company also develops VLA15, a vaccine candidate that is in Phase II clinical trial against Borrelia; VLA1553, a vaccine candidate, which is in Phase III clinical trial against the chikungunya virus; and VLA2001, a vaccine candidate that has completed Phase I/II clinical trial against SARS-CoV-2. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, other European countries, and internationally. The company has collaborations with Pfizer to co-develop and commercialize its Lyme disease vaccine; and Instituto Butantan for the development, manufacturing, and marketing of single-shot chikungunya vaccine. Valneva SE was incorporated in 1999 and is headquartered in Saint-Herblain, France.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellBuy
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Buy
SummaryBuyNeutralStrong SellStrong SellStrong Buy
  • Next week @ 60.00 $
    0
    • Today up to @ 50.00 $
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.